Form 4 Tracker
Artiva Biotherapeutics, Inc.
ARTV

56 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 19, 2026May 20 1:50 AMFred AslanDirector, Chief Executive Officer
Sale
27,116$9.01$244.3K1,535,082(D)

View →

May 18, 2026May 18 11:54 PMHeather Raymon
Proposed Sale
3,500$9.22$32.3K—

View →

May 18, 2026May 18 11:53 PMChristopher P. Horan
Proposed Sale
7,500$9.22$69.2K—

View →

May 18, 2026May 18 11:51 PMJennifer Bush
Proposed Sale
9,000$9.22$83.0K—

View →

May 18, 2026May 18 11:49 PMSubhashis Banerjee
Proposed Sale
7,000$9.22$64.5K—

View →

May 18, 2026May 18 11:48 PMFred Aslan, M.D.
Proposed Sale
28,000$9.22$258.2K—

View →

May 11, 2026May 13 9:45 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Purchase
6,510,416$11.52$75.0M15,203,995(I)

View →

Dec 15, 2025Dec 15 9:18 PMFRED ASLAN
Proposed Sale
12,749$3.30$42.1K—

View →

Nov 17, 2025Nov 17 9:29 PMFRED ASLAN
Proposed Sale
6,375$3.25$20.7K—

View →

Oct 17, 2025Oct 17 8:17 PMFRED ASLAN
Proposed Sale
25,500$2.77$70.6K—

View →

Aug 15, 2025Aug 15 8:24 PMFRED ASLAN
Proposed Sale
25,500$2.70$68.8K—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 27, 2026Aug 31 11:06 PMSubhashis BanerjeeChief Medical Officer
Option Exercise
5,306$1.9274,265(D)

View →

Aug 18, 2026Aug 20 1:00 AMSubhashis BanerjeeChief Medical Officer
Option Exercise
429$1.9279,571(D)

View →

May 18, 2026May 19 12:11 PMGines Diego MirallesPresident & Head of R&D
Grant/Award
232,500$9.22232,500(D)

View →

May 11, 2026May 13 9:45 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Purchase
2,170,138$0.00012,170,138(I)

View →

Feb 18, 2026Feb 20 2:50 AMElaine K. SorgDirector
Grant/Award
27,500$4.1527,500(D)

View →

← Previous

Page 2 of 2